CD8A and neoplasm: They confirmed the upregulation of tumor-specific T-cells activity in the tumor microenvironment, followed by an improved control of tumor growth, by treating mice with commercial probiotics rich in Bifidobacterium, whose beneficial effects were invalidated by their heat inactivation and by depletion of CD8+ T cells.